Short Interest in Aptorum Group Limited (NASDAQ:APM) Rises By 122.0%

Aptorum Group Limited (NASDAQ:APM) was the target of a significant growth in short interest during the month of April. As of April 15th, there was short interest totalling 52,400 shares, a growth of 122.0% from the March 31st total of 23,600 shares. Approximately 1.2% of the company’s shares are sold short. Based on an average daily volume of 110,800 shares, the short-interest ratio is currently 0.5 days.

Aptorum Group Price Performance

Aptorum Group stock opened at $0.98 on Tuesday. The firm has a fifty day simple moving average of $0.90 and a two-hundred day simple moving average of $1.10. Aptorum Group has a twelve month low of $0.46 and a twelve month high of $7.49.

About Aptorum Group

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.